Oruka Therapeutics, Inc.

Market Cap

$3B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$64.06+$35.79 (+126.60%)

Jun 8, 2026

52W High $76.3952W Low $10.90

Company Details

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-...

CEO

—

IPO Date

Aug 8, 1997

Website

orukatx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$116M

EPS (Diluted)

Free Cash Flow

-$91M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 13, 2026

FY 2025

Mar 13, 2026

Q4 2025

Mar 13, 2026

Q3 2025

Nov 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee